Announcement: Most Cannabis Users Unaware of THC Potency, but Psychosis Risk Evidence Is Clear

Last updated: 10/08/2026 07:30

0 Min Read

Consumer awareness of THC concentration in cannabis products remains low, but scientific evidence linking THC dose to psychosis risk is unambiguous and replicated across 76,000+ participants. Evidence shows the relationship is dose-dependent and increases with rising product potency. — Photo by Sadi Hockmuller on Pexels (Pexels License)

1 min read|48 words

Most cannabis users don't know the THC concentration in what they're consuming—but the science is clear: the dose–response relationship between THC and psychosis risk is well-established across 76,000+ participants and consistently replicated. Higher potency products = higher psychosis risk.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Most Cannabis Users Unaware of THC Potency, but Psychosis Risk Evidence Is Clear →

Share This Article

ByProf. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Announcement: Most Cannabis Users Unaware of THC Potency, but Psychosis Risk Evidence Is Clear

Submit Your Paper →

What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained

UK childhood vaccination coverage holds steady at high levels, latest quarterly data shows

EMA Launches Email Notifications for Clinical Trial Information System

Submit Your Paper to GMJ

Company

You Might Also Like